Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K, Ninomiya I, Ohbatake Y, Hirose A, Tsukada T, Nakanuma S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Hidehiro T, Takamura H, Fushida S, Ohta T.
Okamoto K, et al. Among authors: sakai s.
Oncol Rep. 2016 Dec;36(6):3333-3342. doi: 10.3892/or.2016.5133. Epub 2016 Sep 28.
Oncol Rep. 2016.
PMID: 27748881